Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia ()
Eric L. Matteson, Tim Bongartz, Jay H. Ryu, Cynthia S. Crowson, Thomas E. Hartman, Paul F. Dellaripa
Open Journal of Rheumatology and Autoimmune Diseases
Vol.2 No.3,
August 21, 2012
DOI:
10.4236/ojra.2012.23011 5,039 Downloads 8,886 Views
Citations
This article belongs to the Special Issue on
to be published